Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
Figure 10.Associations between AKAP8L expression and the PFI in different clinical subgroups of KIRC. (A) Age > 60; (B) Race: White; (C) Hemoglobin: Low; (D) Histologic grade: G3&G4.